Holen Sie sich die Stockscreener-App
7.46
4.73%
-0.37
Handel nachbörslich:
7.51
0.05
+0.67%
Vicarious Surgical Inc Aktie (RBOT) Neueste Nachrichten
Published on: 2025-08-15 06:11:29 - thegnnews.com
Vicarious Surgical outlines new CEO transition and strategic shift to production system readiness amid $50M cash burn target - MSN
Vicarious Surgical appoints new CEO; co-founder Adam Sachs to remain as president - MSN
Using data tools to time your Vicarious Surgical Inc. exit2025 Macro Impact & Short-Term High Return Strategies - Newser
Vicarious Surgical’s Earnings Call: Progress Amid Challenges - MSN
Vicarious Surgical delays robot clinical timeline - Yahoo Finance
How hedge fund analytics apply to Vicarious Surgical Inc. Equity Warrant stockQuarterly Trade Report & Precise Buy Zone Tips - Newser
Best data tools to analyze Vicarious Surgical Inc. Equity Warrant stockJuly 2025 Sector Moves & Real-Time Volume Surge Alerts - Newser
Vicarious Surgical Inc. stock volume spike explainedTrade Risk Summary & Community Trade Idea Sharing - Newser
Regression analysis insights on Vicarious Surgical Inc. performanceWeekly Investment Recap & Weekly Watchlist of Top Performers - Newser
What does recent volatility data suggest for Vicarious Surgical Inc.Analyst Upgrade & Smart Investment Allocation Insights - Newser
Using economic indicators to assess Vicarious Surgical Inc. potentialPortfolio Value Summary & Low Drawdown Investment Ideas - Newser
Trend analysis for Vicarious Surgical Inc. this weekBuy Signal & Growth Oriented Trade Recommendations - Newser
What MACD and RSI say about Vicarious Surgical Inc.July 2025 Summary & Expert Approved Trade Ideas - Newser
Vicarious Surgical delays robot timeline - MedTech Dive
RBOT Plunges 24.6%: Leadership Shift and Sector Turbulence Spark Investor Frenzy - AInvest
What institutional flow reveals about Vicarious Surgical Inc.2025 Stock Rankings & Real-Time Volume Triggers - Newser
Piper Sandler lowers Vicarious Surgical stock price target on delayed clinical use By Investing.com - Investing.com South Africa
Piper Sandler lowers Vicarious Surgical stock price target on delayed clinical use - Investing.com Australia
Tools to monitor Vicarious Surgical Inc. Equity Warrant recovery probabilityMarket Sentiment Summary & Proven Capital Preservation Methods - Newser
Will Vicarious Surgical Inc. rebound enough to break evenJuly 2025 Movers & Daily Oversold Bounce Ideas - Newser
Vicarious Surgical Inc. (NYSE:RBOT) Q2 2025 Earnings Call Transcript - Insider Monkey
Earnings visualization tools for Vicarious Surgical Inc.2025 AllTime Highs & Reliable Intraday Trade Alerts - Newser
Live market analysis of Vicarious Surgical Inc.July 2025 Macro Moves & Low Risk Entry Point Guides - Newser
Tick level data insight on Vicarious Surgical Inc. volatilityMarket Sentiment Report & Low Risk Profit Maximizing Plans - Newser
Combining price and volume data for Vicarious Surgical Inc. Equity Warrant2025 Year in Review & Free High Accuracy Swing Entry Alerts - Newser
Is Vicarious Surgical Inc. Equity Warrant forming a bottoming baseRecession Risk & Fast Exit/Entry Strategy Plans - Newser
Vicarious Surgical Narrows Loss in Q2 - AOL.com
Can Vicarious Surgical Inc. Equity Warrant recover in the next quarterProfit Target & Fast Gaining Stock Strategy Reports - Newser
Vicarious Surgical Inc (RBOT) Q2 2025 Earnings Call Highlights: Strategic Delays and Cost Reductions By GuruFocus - Investing.com Canada
Published on: 2025-08-13 09:06:39 - beatles.ru
Published on: 2025-08-13 01:02:27 - Newser
Will Vicarious Surgical Inc. Equity Warrant outperform the marketEarnings Growth Report & Real-Time Volume Analysis - Newser
Vicarious Surgical Reports Improved Q2 Financials and Leadership Change - TipRanks
Will a bounce in Vicarious Surgical Inc. Equity Warrant offer an exitNew Guidance & Expert Approved Momentum Trade Ideas - Newser
Vicarious Surgical's Q2 2025: Unraveling Contradictions in Clinical Trials, System Readiness, and Supply Chain Stability - AInvest
Vicarious Surgical Narrows Loss in Q2 - The Motley Fool
Statistical indicators supporting Vicarious Surgical Inc.’s strength [Earnings Summary Report]Low Drawdown Investment Ideas - Newser
Price momentum metrics for Vicarious Surgical Inc. Equity Warrant explained [Market Risk Analysis] - Newser
Earnings call transcript: Vicarious Surgical’s Q2 2025 results show cost efficiency - Investing.com
Transcript : Vicarious Surgical Inc., Q2 2025 Earnings Call, Aug 12, 2025 - MarketScreener
Surgical Robotics Pioneer Vicarious Cuts Losses 13% as New CEO Takes Helm - Stock Titan
Vicarious Surgical Reports Second Quarter 2025 Financial Results - Bluefield Daily Telegraph
Real time social sentiment graph for Vicarious Surgical Inc.Free Price Action Based Buy Opportunity List - Newser
Why Vicarious Surgical Inc. Equity Warrant stock attracts strong analyst attentionFree Entry Alert With Low Drawdown Strategy - Newser
How sentiment analysis helps forecast Vicarious Surgical Inc.Smart Entry Signals for Active Traders - Newser
What analysts say about Vicarious Surgical Inc. Equity Warrant stock outlookReal-Time Signal Tracking with Entry Level - Newser
Why Vicarious Surgical Inc. stock attracts strong analyst attentionAccurate Forecast System with AI Support - Newser
SEC Filings Archive 2025-08-11Historical 10-K, 10-Q, 8-K Forms - Stock Titan
2.30%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):